{"success":true,"data":{"pressRelease":{"id":"162742","rtpr_id":"nBw9bKkTLa-20261007","ticker":"EW","exchange":"NYSE","all_tickers":["EW"],"title":"Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026","author":"Business Wire","published_at":"2026-10-07T10:00:00.175Z","article_body":"Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026\n\nEdwards Lifesciences (NYSE: EW) plans to announce its operating results for\nthe quarter ended Sept. 30, 2026 after the market closes on Wednesday, Nov. 4,\nand will host a conference call at 5:00 p.m. ET that day to discuss those\nresults.\n\nTo participate in the conference call, dial (877) 704-2848 or (201) 389-0893.\nThe call will also be available live and archived on the “Investor\nRelations” section of the Edwards website at ir.edwards.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fir.edwards.com&esheet=54615174&newsitemid=20261007652284&lan=en-US&anchor=ir.edwards.com&index=1&md5=70e8b4e75e50d0358c679dcf199379c1)\n.\n\nAbout Edwards Lifesciences\n\nEdwards Lifesciences is the leading global structural heart innovation\ncompany, driven by a passion to improve patient lives. Through breakthrough\ntechnologies, world-class evidence and partnerships with clinicians and\nhealthcare stakeholders, our employees are inspired by our patient-focused\nculture to deliver life-changing innovations to those who need them most.\nDiscover more at www.edwards.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.edwards.com&esheet=54615174&newsitemid=20261007652284&lan=en-US&anchor=www.edwards.com&index=2&md5=c01020601ba97df1fa3aa959ec219820)\nand follow us on LinkedIn, Facebook, Instagram and YouTube.\n\nEdwards, Edwards Lifesciences, and the stylized E logo are trademarks of\nEdwards Lifesciences Corporation. All other trademarks are the property of\ntheir respective owners.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20261007652284/en/\n(https://www.businesswire.com/news/home/20261007652284/en/)\n\nMedia Contact: Eric Endicott media@edwards.com \n(mailto:media@edwards.com) \nInvestor Contact: Gerianne Sarte Investor_Relations@edwards.com\n(mailto:Investor_Relations@edwards.com)\n\n\nCopyright Business Wire 2026","article_body_html":"","raw_payload":{"data":{"id":"nBw9bKkTLa-20261007","title":"Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026","author":"Business Wire","ticker":"EW","created":"2026-10-07T10:00:00.175Z","tickers":["EW"],"exchange":"NYSE","article_body":"Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026\n\nEdwards Lifesciences (NYSE: EW) plans to announce its operating results for\nthe quarter ended Sept. 30, 2026 after the market closes on Wednesday, Nov. 4,\nand will host a conference call at 5:00 p.m. ET that day to discuss those\nresults.\n\nTo participate in the conference call, dial (877) 704-2848 or (201) 389-0893.\nThe call will also be available live and archived on the “Investor\nRelations” section of the Edwards website at ir.edwards.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fir.edwards.com&esheet=54615174&newsitemid=20261007652284&lan=en-US&anchor=ir.edwards.com&index=1&md5=70e8b4e75e50d0358c679dcf199379c1)\n.\n\nAbout Edwards Lifesciences\n\nEdwards Lifesciences is the leading global structural heart innovation\ncompany, driven by a passion to improve patient lives. Through breakthrough\ntechnologies, world-class evidence and partnerships with clinicians and\nhealthcare stakeholders, our employees are inspired by our patient-focused\nculture to deliver life-changing innovations to those who need them most.\nDiscover more at www.edwards.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.edwards.com&esheet=54615174&newsitemid=20261007652284&lan=en-US&anchor=www.edwards.com&index=2&md5=c01020601ba97df1fa3aa959ec219820)\nand follow us on LinkedIn, Facebook, Instagram and YouTube.\n\nEdwards, Edwards Lifesciences, and the stylized E logo are trademarks of\nEdwards Lifesciences Corporation. All other trademarks are the property of\ntheir respective owners.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20261007652284/en/\n(https://www.businesswire.com/news/home/20261007652284/en/)\n\nMedia Contact: Eric Endicott media@edwards.com \n(mailto:media@edwards.com) \nInvestor Contact: Gerianne Sarte Investor_Relations@edwards.com\n(mailto:Investor_Relations@edwards.com)\n\n\nCopyright Business Wire 2026"},"type":"article","timestamp":"2026-10-07T10:00:00.243735525Z","server_sent_at_ms":1791367200243},"received_at":"2026-10-07T10:00:00.295Z","source_url":"https://www.businesswire.com/news/home/20261007652284/en/"},"analysis":{"id":"151218","press_release_id":"162742","analysis_json":{"industry":{"label":"Health Care Equipment & Supplies","sector":"Health Care"},"redFlags":[],"eventType":"other","narrative":"Edwards Lifesciences will announce Q3 2026 operating results after market close on Wednesday, Nov. 4, 2026.\n\nA conference call to discuss the results is scheduled for 5:00 p.m. ET the same day, with dial-in and webcast access via ir.edwards.com.\n\nNo financial results are included in this notice; it is purely a scheduling announcement.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Calendar note -- set a reminder for EW's Q3 earnings call on Nov. 4 at 5pm ET."},"keyFigures":{},"namedEntities":{"people":[{"name":"Eric Endicott","role":"Media Contact"},{"name":"Gerianne Sarte","role":"Investor Contact"}],"products":[],"companies":[{"name":"Edwards Lifesciences","ticker":"EW"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"This is a scheduling notice only -- it announces when Q3 results and the conference call will occur, with no figures or guidance."},"tickerRelevance":{"others":[],"primary":"EW"},"globalImportance":5,"audienceRelevance":20,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"large-cap","eventGravity":"earnings-date-notice","householdBrandBoost":0}},"event_type":"other","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Edwards Lifesciences will announce Q3 2026 operating results after market close on Wednesday, Nov. 4, 2026.\n\nA conference call to discuss the results is scheduled for 5:00 p.m. ET the same day, with dial-in and webcast access via ir.edwards.com.\n\nNo financial results are included in this notice; it is purely a scheduling announcement.","key_figures":{},"named_entities":{"people":[{"name":"Eric Endicott","role":"Media Contact"},{"name":"Gerianne Sarte","role":"Investor Contact"}],"products":[],"companies":[{"name":"Edwards Lifesciences","ticker":"EW"}],"dollarAmounts":[]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:5c812bd9e28b810d","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-07T10:00:04.416Z","global_importance":5,"audience_relevance":20,"importance_components":{"tickerTier":"large-cap","eventGravity":"earnings-date-notice","householdBrandBoost":0}},"durationMs":4103,"modelName":"glm-5.3-flashx"}}